Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,725,574 papers from all fields of science
Search
Sign In
Create Free Account
Metastatic Endometrial Carcinoma
Known as:
endometrial carcinoma, metastatic
, stage IV carcinoma of the endometrium
, Stage IV Cancer of the Corpus Uteri AJCC v6
Expand
Stage IV includes: IVA: (T4, Any N, M0); IVB: (Any T, Any N, M1). T4: Tumor invades bladder mucosa and/or bowel mucosa (bullous edema is not…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Body of uterus
Endometrium
Female Reproductive System
Malignant Epithelial Cell
Expand
Broader (1)
Endometrial neoplasm malignant metastatic
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The role of platinum rechallenge as second line chemotherapy for metastatic endometrial carcinoma.
R. P. Souza
,
G. Soares
,
+7 authors
M. Estevez-Diz
2016
Corpus ID: 81381881
e17108Background: Combination chemotherapy with taxane and platinum, with or without anthracycline, has been the standard first…
Expand
Review
2014
Review
2014
Anthracycline‐based chemotherapy in metastatic endometrial carcinoma: An update
G. Colloca
,
A. Venturino
Asia-Pacific Journal of Clinical Oncology
2014
Corpus ID: 206982721
The purpose of this review is to analyze clinical evidence about the activity and efficacy of anthracycline‐based chemotherapy in…
Expand
2011
2011
Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
J. Thigpen
2011
Corpus ID: 74866190
2009
2009
Results from a phase II study to assess the efficacy and tolerability of fulvestrant 250 mg/month as treatment of recurrent or metastatic endometrial carcinoma.
Gunter Emons
,
A. Guenthert
,
+7 authors
K. Rensing
Journal of Clinical Oncology
2009
Corpus ID: 32925322
5532 Background: Fulvestrant (F) is a pure anti-estrogen with no agonistic action and no known adverse effects on the endometrium…
Expand
2006
2006
Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma
H. Karagol
,
P. Saip
,
K. Uygun
,
S. Kucucuk
,
A. Aydıner
,
E. Topuz
Medical Oncology
2006
Corpus ID: 30067613
BackgroundPrognostic factors related to survival in patients with inoperable metastatic or recurrent endometrial carcinoma (MREC…
Expand
1998
1998
[Cicatricial pemphigoid with autoantibodies to laminin 5 (epiligrin) in a patient with metastatic endometrial carcinoma].
P. Lenz
,
R. Hsu
,
+4 authors
R. Kirnbauer
Der Hautarzt; Zeitschrift fur Dermatologie…
1998
Corpus ID: 27062268
A 71-year-old female patient presented with erosions of the oral, genital and ocular mucosa, but without skin lesions. One year…
Expand
1996
1996
Metastatic endometrial carcinoma: Rare cause of extrahepatic obstructive jaundice
P. Ritota
,
T. E. Quirke
,
R. Keys
,
A. Byer
1996
Corpus ID: 196357281
We report a very rare case of endometrial carcinoma causing extrahepatic bile duct obstruction. Management of this case and…
Expand
Review
1995
Review
1995
[Chemotherapy of metastatic endometrial carcinoma. Review of the literature].
J. Pierga
,
V. Diéras
,
D. Paraiso
,
P. Pouillart
Bulletin du Cancer
1995
Corpus ID: 27190916
Endometrial carcinoma is one of the most common gynaecological cancers in Western countries. About 75% of the patients present…
Expand
1994
1994
Treatment of recurrent and metastatic endometrial carcinoma with cisplatin and doxorubicin.
M. Deppe
,
V. Malviya
,
J. Malone
,
C. Christensen
,
D. Saunders
European Journal of Gynaecological Oncology
1994
Corpus ID: 7976628
Between April 1985 and February 1989, 19 patients with advanced or recurrent endometrial carcinoma were treated with the…
Expand
1986
1986
Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinoma.
Piver Ms
,
S. Lele
,
B. Patsner
,
Lawrence J. Emrich
Obstetrics and Gynecology
1986
Corpus ID: 20121986
Fifty consecutive patients with recurrent and metastatic endometrial carcinoma were treated with melphalan, 5-fluorouracil, and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE